5096 POSTER Clinical Trial Simulations to Assess Capecitabine Dose Reduction in Combination With Docetaxel in Second Line Treatment of Metastatic Breast Cancer

Autor: Claret, L., Chanu, P., Lindbom, L., Stark, F. Schaedeli, Gilberg, F., Frey, N., Bruno, R.
Zdroj: In European Journal of Cancer 2011 47 Supplement 1:S359-S359
Databáze: ScienceDirect